hereditary spherocytosis - screening (eosin-5'-maleimide (EMA) staining) Refered Test
Back to main menuEurofins Biomnis code
EMA
Synonyms
- Minkowski - Chauffard disease
Clinic significance
Hereditary spherocytosis, or Minkowski-Chauffard syndrome, is a form of congenital chronic haemolytic anaemia resulting from abnormalities in proteins in the red blood cell membrane.
Flow cytometry by marking with eosin-5'-maleimide (EMA) of transmembrane proteins is n improved replacement for the osmotic fragility test to diagnose hereditary spherocytosis. It sensitivity is > 90% and its specificity is 89¿99% according to studies.
Prenalytics
- 5 mL
- EDTA Whole blood
- Refrigerated
Further information
- The test must be performed within 72 hours after blood draw
- ALWAYS attach the specific clinical information form (R39-INTGB :EMA)
Documents to download
Methodology
Flow Cytometry
Turnaround time
30 days
Pathologist(s) in charge
Refered Test
Specialty
Haematology
Contact(s)
Dr Dominique ENGERAND
Dr Isabelle PETIT
Dr Isabelle PETIT
Phone(s)
+331 49 59 62 70
+331 49 59 16 72
+331 49 59 16 72
Caption
The pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.